Through comprehensive analysis of TCGA and CGGA datasets, we revealed that BCL2 as a G0S2-suppressed target gene that demonstrates low expression in glioblastoma (GBM) (Supplementary Figures 7A, B). The gene discussed is G0S2; the disease is glioblastoma.